S&P 500 Futures
(0.08%) 5 135.75 points
Dow Jones Futures
(0.05%) 38 462 points
Nasdaq Futures
(0.14%) 17 871 points
Oil
(-0.25%) $83.64
Gas
(1.77%) $1.957
Gold
(0.31%) $2 354.50
Silver
(0.52%) $27.68
Platinum
(1.60%) $936.85
USD/EUR
(-0.19%) $0.933
USD/NOK
(-0.34%) $10.99
USD/GBP
(-0.32%) $0.798
USD/RUB
(1.19%) $92.97

Actualizaciones en tiempo real para NuGenerex [NUGX]

Bolsa: OTC Sector: Healthcare Industria: Biotechnology
Última actualización17 may 2023 @ 09:42

0.00% $ 0.000100

Live Chart Being Loaded With Signals

Commentary (17 may 2023 @ 09:42):

NuGenerex Immuno-Oncology, Inc., an oncology company, focuses on the modulation of the immune system to treat cancer. The company is developing immunotherapeutic products and vaccines...

Stats
Volumen de hoy 1.00
Volumen promedio 122.00
Capitalización de mercado 10 030.00
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.00167
ATR14 $0.0360 (36 000.00%)

Volumen Correlación

Largo: 0.00 (neutral)
Corto: 0.00 (neutral)
Signal:(47.227) Neutral

NuGenerex Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NuGenerex Correlación - Moneda/Commodity

The country flag -0.06
( neutral )
The country flag 0.12
( neutral )
The country flag 0.00
( neutral )
The country flag 0.13
( neutral )
The country flag 0.00
( neutral )
The country flag 0.02
( neutral )

NuGenerex Finanzas

Annual 2020
Ingresos: $0.00
Beneficio Bruto: $0.00 (0.00 %)
EPS: $-0.0158
FY 2020
Ingresos: $0.00
Beneficio Bruto: $0.00 (0.00 %)
EPS: $-0.0158
FY 2019
Ingresos: $0.00
Beneficio Bruto: $0.00 (0.00 %)
EPS: $-0.0110

Financial Reports:

No articles found.

NuGenerex

NuGenerex Immuno-Oncology, Inc., an oncology company, focuses on the modulation of the immune system to treat cancer. The company is developing immunotherapeutic products and vaccines. It is developing AE37, a peptide immunotherapeutic vaccine, which is in Phase II clinical trials for the treatment of metastatic triple negative breast cancer. The company was formerly known as Antigen Express, Inc. The company was founded in 1993 and is based in Miramar, Florida. NuGenerex Immuno-Oncology, Inc.is a subsidiary of Generex Biotechnology Corporation.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico